Follow
Kausik Kumar Ray
Kausik Kumar Ray
Professor of Public Health, Imperial College London
Verified email at imperial.ac.uk - Homepage
Title
Cited by
Cited by
Year
Heart disease and stroke statistics—2016 update: a report from the American Heart Association
D Mozaffarian, EJ Benjamin, AS Go, DK Arnett, MJ Blaha, M Cushman, ...
circulation 133 (4), e38-e360, 2016
58261*2016
2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk The Task Force for the management of …
F Mach, C Baigent, AL Catapano, KC Koskinas, M Casula, L Badimon, ...
European heart journal 41 (1), 111-188, 2020
4990*2020
Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies
Emerging Risk Factors Collaboration
The Lancet 375 (9733), 2215-2222, 2010
47622010
Evolocumab and clinical outcomes in patients with cardiovascular disease
MS Sabatine, RP Giugliano, AC Keech, N Honarpour, SD Wiviott, ...
New England Journal of Medicine 376 (18), 1713-1722, 2017
44512017
Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes mellitus
BM Scirica, DL Bhatt, E Braunwald, PG Steg, J Davidson, B Hirshberg, ...
New England Journal of Medicine 369 (14), 1317-1326, 2013
38232013
Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials
N Sattar, D Preiss, HM Murray, P Welsh, BM Buckley, AJM de Craen, ...
The Lancet 375 (9716), 735-742, 2010
29272010
Major lipids, apolipoproteins, and risk of vascular disease
R Assessment
Jama 302 (18), 1993-2000, 2009
27352009
Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: consensus statement of …
BG Nordestgaard, MJ Chapman, SE Humphries, HN Ginsberg, L Masana, ...
European heart journal 34 (45), 3478-3490, 2013
25322013
C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis
Emerging Risk Factors Collaboration
The Lancet 375 (9709), 132-140, 2010
25172010
2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: the Task Force for the management of acute …
JP Collet, H Thiele, E Barbato, O Barthélémy, J Bauersachs, DL Bhatt, ...
European heart journal 42 (14), 1289-1367, 2021
25132021
American heart association council on epidemiology and prevention statistics committee and stroke statistics subcommittee
EJ Benjamin, SS Virani, CW Callaway, AM Chamberlain, AR Chang, ...
Heart disease and stroke statistics-2018 update: a report from the American …, 2018
24032018
Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European …
BA Ference, HN Ginsberg, I Graham, KK Ray, CJ Packard, E Bruckert, ...
European heart journal 38 (32), 2459-2472, 2017
22382017
Lipoprotein (a) as a cardiovascular risk factor: current status
BG Nordestgaard, MJ Chapman, K Ray, J Borén, F Andreotti, GF Watts, ...
European heart journal 31 (23), 2844-2853, 2010
18942010
Effect of intensive control of glucose on cardiovascular outcomes and death in patients with diabetes mellitus: a meta-analysis of randomised controlled trials
KK Ray, SRK Seshasai, S Wijesuriya, R Sivakumaran, S Nethercott, ...
The Lancet 373 (9677), 1765-1772, 2009
17512009
Risk of incident diabetes with intensive-dose compared with moderate-dose statin therapy: a meta-analysis
D Preiss, SRK Seshasai, P Welsh, SA Murphy, JE Ho, DD Waters, ...
Jama 305 (24), 2556-2564, 2011
17272011
Lipoprotein (a) concentration and the risk of coronary heart disease, stroke, and nonvascular mortality
Emerging Risk Factors Collaboration
JAMA: the journal of the American Medical Association 302 (4), 412, 2009
15422009
Triglyceride-rich lipoproteins and high-density lipoprotein cholesterol in patients at high risk of cardiovascular disease: evidence and guidance for management
MJ Chapman, HN Ginsberg, P Amarenco, F Andreotti, J Borén, ...
European heart journal 32 (11), 1345-1361, 2011
14532011
Statin-associated muscle symptoms: impact on statin therapy—European Atherosclerosis Society consensus panel statement on assessment, aetiology and management
ES Stroes, PD Thompson, A Corsini, GD Vladutiu, FJ Raal, KK Ray, ...
European heart journal 36 (17), 1012-1022, 2015
13012015
C-reactive protein, fibrinogen, and cardiovascular disease prediction
Emerging Risk Factors Collaboration
New England Journal of Medicine 367 (14), 1310-1320, 2012
11802012
2021 ESC Guidelines on cardiovascular disease prevention in clinical practice: Developed by the Task Force for cardiovascular disease prevention in clinical practice with …
FLJ Visseren, F Mach, YM Smulders, D Carballo, KC Koskinas, M Bäck, ...
European heart journal 42 (34), 3227-3337, 2021
11162021
The system can't perform the operation now. Try again later.
Articles 1–20